CENEXEL
Live / Registered — Registered (as of 23 Nov 2021)
What this means for you
Registered since 23 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88318336
- Registration number
- 6569746
- Mark type
- Stylized text
- Filed
- 27 Feb 2019
- Published for opposition
- 02 Jul 2019
- Registered
- 23 Nov 2021
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical and Scientific research and development services; Pharmaceutical products development; Pharmaceutical drug development services; Clinical research in the field of medicine, therapeutics and pharmaceutical development, namely, psychiatry, neurology, analgesia, metabolic diseases and disorders, endocrinology, dermatology, infectious diseases, and women's health; Conducting clinical trials for others; Drug discovery services; Consulting services in the field of pharmaceutical research and development; research and development services in the fields of psychiatry, neurology, analgesia, metabolic diseases and disorders, endocrinology, dermatology, infectious diseases, and women's health; consulting services for others in the field of design, planning, and implementation project management of clinical trials
Owner
- CENEXEL CLINICAL RESEARCH, INC., MURRAY, UT, US
- CENEXEL CLINICAL RESEARCH, INC., MURRAY, UT, US
- JBR Clinical Research, Inc., Salt Lake City, UT, US
- JBR Clinical Research, Inc., Salt Lake City, UT, US
Prosecution history
- 17 Jul 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 23 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
- 19 Oct 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Oct 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Oct 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Oct 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Oct 2021 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 29 Apr 2021 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 29 Apr 2021 — FINAL REFUSAL E-MAILED
- 29 Apr 2021 — SU - FINAL REFUSAL - WRITTEN
- 06 Apr 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Apr 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Mar 2021 — ASSIGNED TO LIE
- 24 Mar 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Sept 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED